Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The macula is the central part of the retina and is responsible for our fine detailed vision
Eric Blouin, SVP, oncology, healthcare (North America) Drug: Daraxonrasib Company: Revolution Medicines Indication: Pancreatic ductal adenocarcinoma (PDAC) Stage: Phase III Background: Daraxonrasib (RMC-6236) is an oral, direct RAS(on) multiselective inhibitor designed to treat cancers driven by oncogenic RAS mutations, an important driver in PDAC
Quality assurance procedures include High-Performance Liquid Chromatography (HPLC) purity analysis, molecular identity confirmation, and rigorous batch-specific quality control testing
For hair research, AHK-Cu is primarily used topically applied to the scalp surface where it penetrates to reach dermal papilla cells at the follicle base
US$ 27.54
US$ 26.96
US$ 22.62
.webp)